Megakaryoblastic leukemia 1 (MKL1), identified as part of the t(1;22) translocation specific to acute megakaryoblastic leukemia, is highly expressed in differentiated muscle cells and promotes muscle differentiation by activating serum response factor (SRF). Here we show that MKL1 expression is upregulated during murine megakaryocytic differentiation, and that enforced 
Introduction
Acute Megakaryoblastic Leukemia (AMKL, or AML variant M7) is associated with at least two distinct cytogenetic abnormalities, trisomy of chromosome 21 1,2 and the reciprocal t(1;22)(p13;q13) chromosomal translocation [3] [4] [5] [6] [7] . Both types of AMKL are characterized by an expansion of megakaryoblasts in the bone marrow, myelofibrosis and thrombocytopenia 8 . The reciprocal t(1;22)(p13;q13) chromosomal translocation [4] [5] [6] [7] results in the fusion of RNA binding motif protein 15 (RBM15, also known as OTT) and MKL1 (also known as BSAC, MAL, and MRTF-A) genes on chromosomes 1 and 22, respectively. Although both reciprocal fusion transcripts are expressed in AMKL, RBM15-MKL1 encompasses all of the putative functional motifs encoded by each gene, and is thus the candidate oncoprotein of the t(1;22) translocation 7 .
Investigations into the role of RBM15 suggest that it may inhibit myeloid differentiation by modulating the Notch1 signaling pathway 9, 10 . No role for MKL1 has yet been defined in hematopoietic differentiation.
MKL1 is a member of the myocardin family of transcriptional coactivators with MKL2 (also known as MRTF-B) and myocardin. This family has several highly conserved domains including RPEL (arginine, proline, glutamic acid, and leucine) repeats in the N-terminus that bind actin 11 ; a B-box and a glutamine-rich domain, which bind SRF 11 ; a leucine zipper-like domain that may play a role in homo-and hetero-dimerization 11 ; and a C-terminal transactivation domain. All myocardin family proteins bind SRF and activate transcription from promoters with SRF binding sites called serum response elements (SRE) 11, 12 . Regulation of MKL1 activity has been studied in fibroblast and muscle cell differentiation 13, 14 . Until it is activated, MKL1 is bound to monomeric G-actin and cycles between the cytoplasm and the nucleus. When RhoA activates actin
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From polymerization (F-actin formation), MKL1 is released from G-actin and accumulates in the nucleus, where it functions as a coactivator to turn on SRF target genes 15 . MKL1 can dimerize with other myocardin family members, and is required for RhoA-mediated SRF induction of immediate early and muscle specific genes 13 . MKL1 inhibits tumor necrosis factor (TNF)-induced cell death in embryonic fibroblasts 16 , which may be relevant to its role in leukemia.
MKL1 is a critical mediator of the transforming growth factor beta (TGF-β1)-induced epithelialmesenchymal transition via Smad3 17 . Mice lacking MKL1 expression either die in utero due to cardiac abnormalities or develop to birth but have abnormal mammary gland function 18, 19 . Until now, hematopoiesis and in particular megakaryocytopoiesis have not been studied in these mice.
Megakaryocytes are large, polyploid cells of the hematopoietic tissues, whose final differentiation step involves the release of platelets into the bloodstream. The differentiation sequence of megakaryocytopoiesis progresses from hematopoietic stem/progenitor cells, to more committed biphenotypic megakaryocyte-erythroid precursors 20 , burst-forming unitmegakaryocytes (BFU-MK), colony forming unit megakaryocytes (CFU-MK), and megakaryoblasts 21 . Maturation continues with the cells enlarging as they undergo endomitosis, which results in polyploid megakaryocytes. After polyploidization, proplatelet formation begins, which involves complex cytoskeletal rearrangements 22 , and is a prerequisite for platelet release.
In order to better understand the mechanism by which the RBM15-MKL1 translocation causes defects in megakaryocytic differentiation associated with AMKL, we need to know the normal roles of the component proteins. Although previous reports suggest that MKL1 is ubiquitously expressed 6 , we demonstrate that the MKL1 expression level increases significantly during megakaryocytopoiesis, suggesting that MKL1 plays a role in megakaryocyte maturation. We 
Materials and Methods

Stable transfection of HEL cells with inducible MKL1
HEL (Human Erythroleukemia) cells were cultured in RPMI 1640 medium supplemented with 10% fetal calf serum, 2 mM L-glutamine and penicillin/streptomycin at 37°C in 5% CO 2 in a humidified incubator. To induce differentiation, 2x10 5 
Murine peripheral blood counts
Mice were anesthetized with Methoxyflurane (Medical Developments International, Australia)
followed by retro-orbital bleeding (approximately 100 µL) using EDTA treated glass capillary tubes. The blood was evacuated into tubes with 5ul of 0.5M EDTA to prevent clot formation.
The CBC count of blood sample was performed by using a Hemavet 950FS (Drew Scientific, Oxford, CT) according to manufacturer's protocol.
Serum Tpo concentration measurement
Quantikine Murine Tpo Immunoassay Kit (R&D Systems, Minneapolis, MN) was used to quantify Tpo concentration in harvested sera according to the manufacturer's protocol.
Primary murine megakaryocyte enrichment
Primary megakaryocytes were derived from murine E12. 
Real time RT-PCR
Total RNA was isolated using the High Pure RNA Isolation Kit (Roche). For samples with less than 5x10 4 cells, total RNA was extracted using the RNAqueous-Micro Kit (Applied Biosystems/Ambion, Texas). For all RNA samples, genomic DNA were digested with RNasefree DNase I. cDNA was prepared using Superscript II Reverse Transcriptase (Invitrogen) with random primers (Invitrogen). Gene expression levels were determined using Applied Biosystems TaqMan(R) Gene Expression Assays: murine Mkl1: Mm00461840_m1; murine Kit:
Mm00445212_m1; murine Gata1: Mm01352636_m1; Murine Nfe2: Mm00801891_m1, and detected by iCycler iQ (BioRad). Eukaryotic18S rRNA: Hs99999901_s1 was used as an internal control for normalization. Standard curves were performed for each PCR reaction.
RNA interference
The SRF Validated Stealth™ DuoPak 12936-64 (Invitrogen) containing two validated siRNA duplexes was used to decrease SRF transcript levels in the HEL cell line using nucleofection as described. 1. 
Gene Expression Analysis using cDNA Microarrays
HEL/MKL1 and control cells were treated with TPA and doxycycline for 24 hrs, and total RNA prepared from two biological repeats was used on Affymetrix Human Genome U133 Plus 2.0
Arrays (Affymetrix, Santa Clara, CA). Normalization and statistical analysis of the expression data were carried out using the limma software package for the R programming environment 24, 25 .
Differential expression of the combined MKL/control cells' expression data before and after exposure to 1 day of TPA was analyzed using linear model methods 26, 27 . The linear models allowed for assessment of general changes in gene expression between different conditions and across different biological replicates. Each probe was tested for changes in expression based on a bifactorial design in which the presence or absence of exposure to TPA was one factor and doxycycline-inducible activation of MKL1 was the other factor. This test is similar to an ANOVA method for each probe except that the residual standard deviations are moderated across genes, as a compromise between the individual gene wise standard deviations and an (Illumina, San Diego, CA). The Illumina data was quantile normalized using the affy package for the R programming environment. The Illumina data was then analyzed using the limma package to detect genes that were changed in response to MKL overexpression. The 1000 probe sets that were most significantly affected by MKL on both microarray platforms were combined to yield an overlap set of 176 genes.
Statistical Analysis
Statistical significance of differences between different conditions was performed using Prism (GraphPad Software, La Jolla, CA) with a two-tailed unpaired t-test.
Results
Mkl1 is upregulated during murine megakaryocytic differentiation
We first assessed whether Mkl1 is differentially expressed during megakaryocyte differentiation.
Cells from E12.5-E14.5 fetal livers were cultured with TPO, and harvested for RNA daily for
days. On day four, the cells (comprised predominantly of myelomonocytic cells and megakaryocytes) were fractionated on a discontinuous BSA gradient based on cell size 23 . The pellet below the 3% BSA fraction was most enriched (about 80% purity) for fully mature polyploid megakaryocytes based on morphology (data not shown) and DNA content ( Figure 1A ).
Real time qRT-PCR analysis indicated that Mkl1 is expressed throughout megakaryocytic differentiation. However, Mkl1 is expressed at the highest levels on day four ( Figure 1B, left) , and is enriched in the fraction of mature megakaryocytes ( Figure 1B, right) .
In order to further clarify if Mkl1 mRNA levels increase during megakaryocytic maturation as opposed to simply being expressed maximally in megakaryocyte versus other blood cell types, we cultured murine bone marrow cells with TPO for one day, sorted c-kit
+ megakaryocytic progenitors (day one), and differentiated them into mature megakaryocytes in vitro (day two, day five). Due to the active biogenesis during differentiation 29 , we could underestimate the change when the data are normalized to regular internal controls. Therefore, we graphed our quantitative RT-PCR in two ways, normalized to 18S levels ( Figure 1C , left) or to cell number ( Figure 1C, right) . The data showed a 2.26-fold increased in Mkl1 mRNA levels when normalized to 18S, and 26.6-fold increase when normalized to cell number on day five of differentiation ( Figure 1C ). Normalization using HPRT gave a similar fold change as 18S (data not shown). As further confirmation that megakaryocytes were maturing in this culture system (Supplementary Figure 1A) , we found that Nf-e2 and Gata1 mRNA were upregulated, and c-kit was downregulated over time (Supplementary Figure 1B) . In conclusion, Mkl1 is upregulated during megakaryocyte differentiation.
Ectopic expression of MKL1 promotes megakaryocytic differentiation 1 4 The HEL cell line, which can be differentiated along the megakaryocytic and erythroid lineages, was used as a model system to assess the effects of MKL1 on megakaryocyte differentiation.
When HEL cells are treated with TPA, they differentiate into megakaryocyte-like cells which are polyploid, and in which megakaryocyte markers such as CD41a and CD61 are upregulated, while erythroid markers such as glycophorin A are down-regulated 30, 31 .
To examine whether overexpression of MKL1 protein affects megakaryocytic differentiation, we established stably transfected HEL cell clones with doxycycline-inducible MKL1 (Figure 2A ). In the presence of TPA for 4 days, enforced MKL1 expression increased the average percentage of mature megakaryocytes from 42% to 94% based on analysis of Wright-Giemsa stained cytospins (p<0.05) ( Figure 2B, Supplementary Figure 2) . The percentage of cells with 2N ploidy decreased from 45% to 20% (P<0.05), 4N ploidy increased from 30% to 32%, 8N ploidy increased from 17% to 36% (P< 0.05), and 16N ploidy increased from 6% to 10% ( Figure 2C ). Megakaryocytic differentiation is accompanied by increased cell adhesion properties 32 . In the HEL cell system, TPA treated MKL1 overexpressing cells had increased adherence to the culture plates and were more spread out in comparison to control cells ( Figure 2D Figure 2E , enforced MKL1 expression increased CD41a expression from 37% to 61%, CD61 from 37% to 64%, and CD42b from 15% to 39%. Consistent with the HEL cell data, MKL1
overexpression also promotes primary human megakaryocytes to become polyploid. In the CD41a + fraction, the percentage of cells with 2N ploidy decreased from 35% to 23%, 4N ploidy decreased from 31% to 21%, 16N ploidy increased from 9% to 19%, and 32N ploidy increased from 2% to 8% (P< 0.05 ) ( Figure 2F ).
The effects of MKL1 in HEL cells are mediated through SRF
In muscle and fibroblast cells, MKL1 is associated with G-actin. In response to RhoA activation, MKL1 dissociates from G-actin and accumulates in the nucleus where it forms a complex with SRF to activate transcription of SRF target genes 11 . Here we tested whether MKL1 and SRF together play a role in megakaryocytic differentiation. We transiently transfected SRF siRNA into HEL/MKL1 cells and assessed the ploidy in the presence or absence of doxycycline. We first validated that SRF protein was knocked down at least 80% by siRNA whereas the MKL1 protein level was not affected (Supplementary Figure 3) . Figure 3 shows the percentage of cells with 8N ploidy under different culture conditions with doxycycline and transfection of siRNA against SRF. MKL1 overexpression increases the percentage of 8N cells from 4% on day 1 to 34% on day 3 compared to from 4% to 13% in the controls ( Figure 3A , closed squares and closed diamonds, respectively). This effect of MKL1 on ploidy was abrogated when cells were transfected with siRNA against SRF; ploidy increases from 5% on day 1 to only 14% on day 3
( Figure 3A , open circles), indicating that MKL1 acts via SRF to enhance megakaryocytic Figure 3A , closed triangles and closed diamonds, respectively, p=0.02) and in control cells (7% compared to 13% on day 3; Figure 3B , closed triangles and closed diamonds, respectively, p=0.001), suggesting that SRF plays a role in polyploidization. In conclusion, the results show that MKL1 promotes polyploidy through SRF in HEL cells.
To better elucidate the molecular mechanisms by which enforced MKL1 expression enhances megakaryocytic differentiation, we compared the RNA expression profiles of TPA-differentiated HEL/MKL1 cells with and without MKL1 overexpression using both Affymetrix and Illumina microarray platforms. After 24 hours of differentiation with TPA, MKL1 overexpression increased megakaryocytic markers, such as GATA1, GATA2, and GP5 (Supplementary Table 1 , Supplementary Figure 4) . Furthermore, MKL1 expression led to increased expression of cytoskeletal and adhesion molecule genes that are known to be SRF targets [33] [34] [35] (Supplementary Table 1) , and are upregulated during megakaryocytic differentiation [36] [37] [38] , such as CALD1, MYLK, TPM, and MYOM1. Expression data described in this report have been deposited in the Gene Expression Omnibus under the accession series number GSE 13710.
Reduced platelet number in MKL1 knockout mice
In order to determine the role of MKL1 in vivo, we examined the hematopoietic system in MKL1 knockout mice. Complete peripheral blood counts from age-matched littermates of MKL1 KO, HET, and WT mice were performed. Although there were no significant differences in total WBC and RBC counts, the platelet count was significantly decreased in MKL1 KO mice 1 7 ( 
Reduced mature megakaryocyte number and ploidy in MKL1 knockout mice
To investigate whether the reduced platelet number in the MKL1 knockout mice might result from abnormal hematopoiesis, we assessed the BM in these mice. Total BM cellularity is not affected ( Figure 4A ) by knockout of MKL1, and there is no significant difference in the percentage of LSK cells ( Figure 4B ) or PreMegE cells (erythro-megakaryocytic progenitor cells) 20 ( Figure 4C ). We found a slight increase in CFU-MK numbers, but this was not statistically significant ( Figures 4D). CD41 (GPIIb) is expressed throughout megakaryocyte differentiation, starting from early progenitors to mature polyploid megakaryocytes and platelets 39 . Interestingly, there is a significant increase of over 2-fold in the percentage of CD41 + cells in MKL1 KO bone marrow ( Figure 5A ) with essentially identical serum TPO levels ( Figure 5B ). There is also a significant increase of over 2-fold in the percentage of CD41 + c-kit + progenitor cells in MKL1 KO bone marrow, suggesting that the lack of MKL1 leads to expansion of immature megakaryocytes ( Figure 5C ). To quantify the number of mature megakaryocytes, we counted large mature megakaryocytes with typical morphologic characteristics on hematoxylin and eosin stained BM sections (Supplementary Figure 5) . As shown in Figure 5D , there were decreased numbers of mature megakaryocytes in MKL1 KO bone marrow, assessed as number per high power field (HPF; 200x magnification) in each group.
8
To clarify the discrepancy between increased CD41 + percentage and lower absolute count of mature megakaryocytes in MKL1 KO bone marrow, we next examined the ploidy of megakaryocytes in these mice. MKL1 KO CD41 + cells showed significantly decreased ploidy compared to WT cells (see Figure 5E , 5F). The percentage of CD41 + megakaryocytes that were 2N was 32% vs. 15% in KO versus WT mice, respectively (WT n= 6, KO n=8, P < 0.001).
Consistent with this decreased ploidy, there were statistically significantly more WT than KO CD41 + cells with 8N and 16N ploidy (P<0.05). In conclusion, these results suggest that MKL1 deficiency impedes megakaryocyte maturation and polyploidization with a subsequent reduction in platelet counts.
Discussion
The data presented here demonstrate a novel role for MKL1 in regulating megakaryocytopoiesis.
We show that MKL1 expression is upregulated during megakaryocytic differentiation, and that enforced expression of MKL1 in HEL cells enhances megakaryocytic differentiation with upregulation of GATA1, GATA2, and GP5, and increased cell ploidy. We confirm that in primary human CD34 + cells, overexpression of MKL1 promotes megakaryocytic surface marker expression and ploidy. Using siRNA against SRF, we show that, as in differentiating muscle cells, the effects of MKL1 are mediated by SRF. Of note, SRF knockdown in control HEL cells stimulated with TPA also led to a small reduction in polyploidy, suggesting that the inhibitory effects on ploidy are not artifacts of MKL1 overexpression, but rather that endogenous MKL1 acts via SRF to enhance megakaryocyte differentiation. Myocardin-related transcription factors also play a central role in differentiation of vascular smooth muscle cells 40, 41 , which naturally 42 . It will be of interest to determine whether MKL1 has the same role in mediating polyploidization in vascular smooth muscle cells.
In MKL1 deficient bone marrow, there is no significant difference in the total BM cell number or the percentage of cells in the LSK or PreMegE subpopulations, suggesting that earlier stem and progenitor stages are not affected. However, we observe a slight increase in CFU-MK, and a pronounced increase in CD41 + ckit + and CD41 is rich in actin and myosin, and is mediated by a discrete pool of GTP-bound, active RhoA 43 . In the process of megakaryocytic polyploidization, endomitosis occurs due to failure of late cytokinesis related to defects in the contractile ring and Rho/Rock signaling 44 . Whether MKL1 plays a role directly in endomitosis and mediates the RhoA pathway requires further investigation. The characteristics of MKL1 KO megakaryocytes may also be caused by a microenvironmental effect rather than only by a cell-autonomous effect, which will be pursued in future studies.
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Thrombocytopenia is described in MKL1 KO mice. Although we did not observe excess bleeding when collecting retro-orbital blood and the platelet counts are well above those believed to cause bleeding problems, our preliminary data show a slight increase in bleeding time in MKL1 KO mice (data not shown). Whether the MKL1 KO platelets exhibit altered morphology or function should be addressed in future studies. The decreased platelet counts in MKL1 KO mice could be due solely to decreased megakaryocyte ploidy. However, the relationship between ploidy and platelet production is still controversial 8 formation in the BM is abnormal 46, 47 . Since WASp is an important regulator of the actin cytoskeleton 48 , it will be interesting to investigate if the reduced size and number of MKL1 KO platelets is due to the defect in cytoskeleton rearrangement in platelet biogenesis.
One could speculate on how our findings relate to the role of the t(1;22) translocation in AMKL. inhibiting terminal differentiation, which is supported by the findings of Descot et al. 49 .
Importantly, here we show for the first time that MKL1 plays a role in megakaryocytopoiesis, which provides a framework for better understanding the t(1;22) translocation that is found almost uniquely in megakaryoblastic leukemia and not in other subtypes, and have begun to elucidate the mechanisms underlying MKL1 mediated megakaryocytic differentiation. 
Figure Legends
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